Trauma assessment instruments: PCL-5, IES-R, ITQ — what to choose and how to read the result

What a "trauma test" actually measures

The search "trauma test" is among the most common queries in psychodiagnostics. Behind it sit three different clinical questions, each with its own instrument. First: was there exposure to a traumatic event (Criterion A in DSM-5). Second: are post-traumatic symptoms present and how severe. Third: do those symptoms meet criteria for clinical PTSD or complex PTSD. These questions don't collapse into a single questionnaire — and that is the first source of confusion.

Each task is covered by its own validated instrument. LEC-5 (Life Events Checklist for DSM-5) — an exposure inventory, not a diagnostic. PCL-5 — a self-report screen of 20 DSM-5 symptoms. ITQ (International Trauma Questionnaire) — an ICD-11 self-report and the only one that distinguishes classic PTSD from complex PTSD (CPTSD). IES-R — the long-standing tool for tracking response dynamics to a specific event, built on DSM-IV criteria. CAPS-5 — a structured clinical interview, the gold standard for diagnosis. These are different instruments with different targets, and substituting one for another is the central clinical error in trauma work.

Trauma ≠ PTSD: exposure vs clinical response

The single most underrated clinical fact about trauma: between exposure and diagnosis lies an order-of-magnitude gap. Per WHO World Mental Health Surveys analyzing 68,894 respondents across 24 countries (Kessler et al., 2017), 70.3% of adults experience at least one traumatic event in their lifetime; the average is 3.2 event types per person. That is the norm, not the rare case. A parallel analysis of 71,083 respondents across 26 countries in the same program (Koenen et al., 2017) yielded a lifetime PTSD prevalence of 3.9% in the general population and 5.6% among trauma-exposed individuals. In other words, in the vast majority of people, PTSD does not develop after exposure.

That gap is the central clinical question. Which events carry disproportionate risk? Rape, other sexual assault, and stalking together account for roughly 38% of the total PTSD person-year burden, despite being relatively rare on their own. This is interpersonal violence; it carries the top share of risk. Non-interpersonal events (motor vehicle accidents, unexpected death of a loved one, natural disasters) are far more common, but the conditional risk of developing PTSD after them is substantially lower. So in history-taking, the type of event matters as much as the fact of exposure — and LEC-5 is the structured way to capture that.

The third number is comorbidity. A meta-analysis of 57 studies (n = 6,670) by Rytwinski et al. (2013) yielded 52% co-occurring MDD in people with current PTSD. That means any trauma screening unaccompanied by a parallel depression screen (PHQ-9, BDI-II) is clinically incomplete. Similarly with parallel anxiety, sleep disturbance, and substance use. Trauma rarely shows up in isolation.

"Trauma exposure is common throughout the world, unequally distributed, and differential across trauma types with respect to PTSD risk."— Kessler R.C. et al., European Journal of Psychotraumatology, 2017, 8(sup5):1353383

PCL-5 — the DSM-5 self-report gold standard

PCL-5 (PTSD Checklist for DSM-5, Weathers et al., 2013) — 20 items, one per DSM-5 symptom. Symptoms are grouped into four clusters: intrusions, avoidance, negative alterations in cognition and mood, hyperarousal. Scale 0–4, total range 0–80. It takes 5–10 minutes to complete. This is the DSM-5 self-report standard in research and clinical practice, freely distributed through the National Center for PTSD (VA.gov).

The psychometrics are solid. In a sample of 468 veterans (Bovin et al., 2016) internal consistency reached Cronbach α = 0.96, test-retest r = 0.84 at one-week interval. The optimal cut-off for probable PTSD is the 31–33 range; in a subsample of n=140 with CAPS-5 as reference, diagnostic agreement reached κ = 0.58. PCL-5 reliably separates "probably has PTSD" from "probably doesn't", but it does not make the diagnosis. Convergent validity with CAPS-5 is r = 0.66 — moderate, which is the argument for treating PCL-5 and CAPS-5 as not interchangeable. They measure adjacent things, not the same thing.

• Completion time: 5–10 minutes (fast screening + repeated measurements)
• Use: initial screening and progress tracking through therapy
• Cut-off 31–33 — "probable PTSD", requires interview confirmation
• Not suitable for: formal diagnosis without CAPS-5, children under 17 (separate PCL-5-CA exists)
• Russian-language adaptations exist, but cross-validation on your sample is recommended

The main clinical usage pattern: PCL-5 every 4–6 weeks during the active phase of therapy. A clinically meaningful drop is 10–20 points; statistically significant is around 5. If the score doesn't move over 8–12 weeks, that's a signal to revisit the plan — case reformulation, adding a trauma-focused protocol (PE, CPT, EMDR), or referring for CAPS-5 to clarify the diagnosis.

ITQ — what ICD-11 CPTSD diagnosis adds

ITQ (International Trauma Questionnaire, Cloitre et al., 2018) is a self-report instrument developed specifically for the ICD-11 PTSD structure. This is a structural rework, not cosmetic. ICD-11 introduced two diagnoses where DSM-5 has one: classic PTSD and complex PTSD (CPTSD). These are distinct clinical profiles with different treatment targets, and ITQ is the only currently validated self-report way to distinguish them.

Structure: 12 symptom items plus 6 functional impairment items, scale 0–4. ICD-11 PTSD clusters are narrow — three clusters, six core symptoms: re-experiencing, avoidance, sense of threat. CPTSD = PTSD + three additional clusters labelled "disturbances in self-organization" (DSO): affective dysregulation, negative self-concept, disturbances in interpersonal relationships. So CPTSD is PTSD "plus something", and that "something" largely overlaps with what DSM-5 describes via additional diagnoses (BPD, dissociative subtype, persistent depressive disorder).

The ITQ algorithm works at the individual-item level, not the sum. For a cluster to "pass", you need endorsement ≥ 2 on at least one of the cluster's items plus endorsement ≥ 2 on at least one functional impairment item for that cluster. The sum isn't informative — the pattern is. If a client's scores concentrate in the six PTSD items and DSO stays below threshold — that's PTSD. If all three DSO clusters reach threshold in parallel — that's CPTSD. The Soveria platform displays the classification automatically (PTSD / CPTSD / no presentation), but it doesn't replace the clinician — it's a first anchor for the conversation, not a verdict.

Differential diagnosis — CPTSD ≠ BPD. CPTSD and Borderline Personality Disorder are different diagnoses. A latent class analysis by Cloitre et al. (2014) on 280 women with histories of childhood abuse identified four empirically distinct classes (Low Symptom, PTSD, CPTSD, BPD). Four BPD markers that separate it from CPTSD: frantic efforts to avoid abandonment, unstable self-image, unstable and intense interpersonal relationships, impulsivity. In a person with CPTSD, DSO symptoms are pronounced — but those four BPD criteria remain mild. Confusing the two leads to mistreatment.

Practical takeaway. If your client has a history of chronic interpersonal trauma (childhood in an unsafe family, prolonged domestic abuse, captivity, exploitation) and PCL-5 produces a mixed profile or an unusual picture — add ITQ. If ITQ flags CPTSD, treatment tactics change: resource stabilization and self-organization work come before exposure protocols, not instead of them. This is the ISTSS 2018 recommendation for complex PTSD.

A validation relevant to Russian-speaking contexts: Ho and colleagues (2023) tested ITQ on a sample of 2,004 Ukrainian civilians roughly 6 months after the full-scale invasion of 2022. The structure was confirmed; reliability across six subscales ranged α = 0.73–0.88. That means the instrument works in a post-Soviet culture and under active war-related stress — not only in academic Western samples.

IES-R and LEC-5: dynamics and event inventory

IES-R (Impact of Event Scale – Revised, Weiss & Marmar, 1997) — the long-standing tool for tracking response to a specific traumatic event. 22 items, three subscales: intrusions, avoidance, hyperarousal. Total Cronbach α = 0.92–0.96, subscales 0.79–0.94, test-retest r = 0.89–0.94. The scale anchors to one event, and that is its strength: for longitudinal designs and for tracking work with a specific episode it remains valid and precise.

IES-R limitation: it was built on DSM-IV criteria — that is, before the 2013 revision when PTSD gained its fourth cluster (negative alterations in cognition and mood). So in a DSM-5 context, IES-R falls short of PCL-5 on coverage. Where IES-R remains justified: research with a historical longitudinal arm (if data have been collected since the 1990s, switching instruments mid-stream isn't an option), work with a single specific event at the center of therapy, and non-English adaptations where Russian-language psychometrics are better characterized than for PCL-5.

LEC-5 (Life Events Checklist for DSM-5) — a brief inventory of 17 potentially traumatic event types, without symptom assessment. It is not a diagnostic instrument. It serves as a stem: the client checks what has happened to them (happened to me / witnessed / learned about close one / part of my job / not sure / didn't happen); from that list, an index event is selected, and PCL-5 or CAPS-5 anchors to it. This is the correct DSM-5 workflow: first establish Criterion A (the trauma per criterion), then measure symptoms relative to the index event.

CAPS-5 — the gold standard in the clinician's hands

CAPS-5 (Clinician-Administered PTSD Scale for DSM-5, Weathers et al., 2018) — a structured clinical interview, not a questionnaire. ~45–60 minutes for an experienced clinician to administer; administration requires training. Each of the 20 DSM-5 symptoms is rated on two dimensions — frequency × severity — yielding a 0–4 score per symptom. Beyond symptoms, the interview rates duration, functional impact, and validity of the report (to filter symptom feigning and memory inaccuracy).

The CAPS-5 psychometrics are what keep it the gold standard. Across two veteran samples (n=165 and n=207) Weathers et al. (2018) demonstrated: interrater reliability κ = 0.78–1.00 for diagnosis, ICC = 0.91 for severity; test-retest κ = 0.83 for diagnosis, ICC = 0.78 for severity; internal consistency α = 0.88. Agreement with CAPS-IV (the previous version) is r = 0.83, ensuring backward compatibility with historical studies. This is a reliability ceiling self-report cannot, by design, reach.

Important — CAPS-5 is not for self-administration. It is a structured clinical interview that requires a trained interviewer. In the Soveria catalog, CAPS-5 carries a "Clinician-only" badge for exactly this reason. Attempting it as self-report yields meaningless data — the interview format is built on probing, validity-of-report ratings, and temporal anchoring of symptoms, none of which work in a self-report mode.

When to refer for CAPS-5. After a positive PCL-5 or ITQ screen before starting active trauma-focused therapy (especially when exposure protocols are planned). For documentation requiring formal DSM-5 diagnosis: forensic psychiatric assessment, insurance cases, evaluations for medication decisions. When symptom feigning or conversion is suspected — CAPS-5 in a trained clinician's hands offers an internal-consistency check that self-report cannot.

How to assemble a battery for the task

Bottom-line recommendation: there is no single "trauma test". There is a choice of instruments calibrated to a specific clinical question. Below are five typical workflows for private practice.

• Screening a new client in DSM-5 context. LEC-5 (exposure inventory) → PCL-5 relative to an index event. If the score is ≥ 31–33 — consider referring for CAPS-5 to confirm diagnosis
• Suspecting CPTSD in chronic interpersonal trauma. PCL-5 + ITQ. ITQ separates PTSD and CPTSD profiles. If CPTSD flags — prioritize resource stabilization before exposure
• Tracking progress during active therapy. PCL-5 every 4–6 weeks; IES-R additionally when one specific event sits at the center of the protocol
• Documentation / forensic / insurance cases. CAPS-5 is mandatory. Self-report doesn't hold weight in any serious jurisdiction
• Client self-screening before first session. PCL-5 or ITQ via a secure platform, with results reviewed in session. Never — without subsequent clinical discussion

The principle to keep in mind: self-report tells you "is there something to talk about", a structured interview makes the diagnosis. Don't substitute one for the other. PCL-5 with a score of 45 is not a PTSD diagnosis; it's a substantial reason to look more closely. CAPS-5 without prior screening is an inefficient use of 45 minutes; the correct workflow is screening via PCL-5/ITQ, then CAPS-5 for cases where it is warranted.

A closing point — measurability as a culture of trauma work. Half of PTSD cases in Koenen et al. (2017) are chronic; roughly half of people with severe forms receive any treatment. Structured screening and regular re-measurement don't change those statistics on their own, but they do one important thing: they shift the conversation with the client from "how are you feeling this week?" to a mode where there are numbers to track, discuss, and use as material for decisions. In that sense, a "trauma test" is not a single point but a series. The clinical value lives in the series, not in the first measurement.